Extracorporeal Membrane Oxygenation Complications in Heparin- and Bivalirudin-Treated Patients

Volume: 3, Issue: 7, Pages: e0485 - e0485
Published: Jul 1, 2021
Abstract
OBJECTIVES: Extracorporeal membrane oxygenation is a potentially life-saving intervention in refractory cardiopulmonary failure, but it requires anticoagulation to prevent circuit thromboses, which exposes the patient to hemorrhagic complications. Heparin has traditionally been the anticoagulant of choice, but the direct thrombin inhibitor bivalirudin is routinely used in cases of heparin-induced thrombocytopenia and has been suggested as a...
Paper Details
Title
Extracorporeal Membrane Oxygenation Complications in Heparin- and Bivalirudin-Treated Patients
Published Date
Jul 1, 2021
Volume
3
Issue
7
Pages
e0485 - e0485
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.